Policy changes Backwork has recorded, newest first. The most recent change on record is from October 14, 2026. Changes appear here after Backwork reviews and applies a refresh, so this page can trail the payers’ own sites.
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
83,427 on record
| Recorded | Payer | Policy | Change |
|---|---|---|---|
| Aug 2, 2026 | Blue Cross and Blue Shield of Nebraska | SPECIALTY TESTING: NEPHROLOGY | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Nebraska | SPECIALTY TESTING: GASTROENTEROLOGY | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Nebraska | SPECIALTY TESTING: CARDIOVASCULAR | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Nebraska | SPECIALTY TESTING: NEUROLOGY | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Nebraska | SPECIALTY TESTING: HEMATOLOGY | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Nebraska | SPECIALTY TESTING: MULTISYSTEM GENETIC CONDITIONS | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Nebraska | ONCOLOGY TESTING: SOLID TUMOR MOLECULAR DIAGNOSTICS | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Nebraska | ONCOLOGY TESTING: HEREDITARY CANCER | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Nebraska | ONCOLOGY TESTING: ALGORITHMIC ASSAYS | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Nebraska | ONCOLOGY TESTING: CANCER SCREENING AND SURVEILLANCE | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Nebraska | SPECIALTY TESTING: PHARMACOGENETICS | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Nebraska | URINE DRUG TESTING FOR PAIN MANAGEMENT AND SUBSTANCE USE DISORDER TREATMENT | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Nebraska | OUTPATIENT GASTROINTESTINAL PATHOGEN PANEL | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Nebraska | ANTIGEN LEUKOCYTE ANTIBODY TEST | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Nebraska | NERVE FIBER DENSITY TESTING | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Nebraska | SPECIALTY TESTING: OTOLARYNGOLOGY | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Nebraska | REPRODUCTIVE TESTING: CARRIER SCREENING | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Nebraska | REPRODUCTIVE TESTING: PRENATAL DIAGNOSIS | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Nebraska | MEASUREMENT OF SERUM ANTIBODIES TO INFLIXIMAB AND ADALIMUMAB | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Nebraska | FECAL CALPROTECTIN TESTING | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Nebraska | CARDIOVASCULAR RISK PANELS AND BIOMARKERS | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Nebraska | REPRODUCTIVE TESTING: PRENATAL SCREENING | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Nebraska | MA Renal Denervation for Hypertension | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Nebraska | MA Cardiac Contractility Modulation for Heart Failure | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Nebraska | MA Superficial Radiation Therapy (SRT) for the Treatment of Nonmelanoma Skin Cancer | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Nebraska | MA Unlisted Procedure Codes (Preauthorization Required) | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Nebraska | MA Prostatectomy | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Nebraska | MA Mohs Micrographic Surgery | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Nebraska | MA Specialty Testing: Neurology | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Nebraska | MA Specialty Testing: Hematology | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Nebraska | MA General Approach to Laboratory Testing | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Nebraska | MA Specialty Testing: Cardiovascular | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Nebraska | MA Specialty Testing: Nutrition and Metabolism | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Nebraska | MA Specialty Testing: Transplant | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Nebraska | MA Specialty Testing: Dermatology | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Nebraska | MA Specialty Testing: Orthopedics | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Nebraska | MA Specialty Testing: Immunology and Rheumatology | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Nebraska | MA Specialty Testing: Nephrology | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Nebraska | MA Specialty Testing: Respiratory | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Nebraska | MA Specialty Testing: Gastroenterology | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Nebraska | MA Specialty Testing: Ophthalmology | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Nebraska | MA Specialty Testing: Multisystem Genetic Conditions | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Nebraska | MA Oncology Testing: Hematologic Malignancy Molecular Diagnostics | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Nebraska | MA Oncology Testing: Solid Tumor Molecular Diagnostics | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Nebraska | MA Oncology Testing: Hereditary Cancer | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Nebraska | MA Oncology Testing: Algorithmic Assays | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Nebraska | MA Oncology Testing: Cancer Screening and Surveillance | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Nebraska | MA Specialty Testing: Pharmacogenetics | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Nebraska | MA Specialty Testing: Otolaryngology | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Nebraska | MA Reproductive Testing: Carrier Screening | New policy |